We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
-5.35%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.69B
AUM Growth
-$239M
Cap. Flow
+$33.3M
Cap. Flow %
1.24%
Top 10 Hldgs %
47.52%
Holding
112
New
16
Increased
29
Reduced
14
Closed
12

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$38M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$36.3M
3
ETNB
89bio
ETNB
+$36.1M
4
BAC icon
Bank of America
BAC
+$33.6M
5
CMG icon
Chipotle Mexican Grill
CMG
+$29.3M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$92M
2
KO icon
Coca-Cola
KO
+$48.2M
3
SBUX icon
Starbucks
SBUX
+$47M
4
CRH icon
CRH
CRH
+$41.5M
5
MCD icon
McDonald's
MCD
+$30M

Sector Composition

Rank Sector Weight
1 Healthcare 60.02%
2 Technology 10.47%
3 Consumer Discretionary 6.61%
4 Financials 5.33%
5 Communication Services 4.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
26
Oracle
ORCL
$423B
$31.6M 1.17%
226,318
– –
TSLA icon
27
Tesla
TSLA
$1.3T
$31.6M 1.17%
122,016
-41,614
-25% -$13.9M
BAC icon
28
Bank of America
BAC
$442B
$31.5M 1.17%
+753,913
New +$33.6M
KO icon
29
Coca-Cola
KO
$375B
$29.8M 1.1%
415,720
-722,133
-63% -$48.2M
CMG icon
30
Chipotle Mexican Grill
CMG
$41.5B
$27.1M 1.01%
+539,540
New +$29.3M
MLYS icon
31
Mineralys Therapeutics
MLYS
$2.41B
$26.5M 0.98%
+1,667,759
New +$19.2M
BSX icon
32
Boston Scientific
BSX
$71.5B
$26.4M 0.98%
262,099
-135,580
-34% -$13.7M
UAL icon
33
United Airlines
UAL
$42.1B
$25.3M 0.94%
366,375
+165,725
+83% +$15.7M
RCKT icon
34
Rocket Pharmaceuticals
RCKT
$394M
$23.4M 0.87%
3,502,000
+935,049
+36% +$9.24M
FERG icon
35
Ferguson
FERG
$49.8B
$20.8M 0.77%
129,924
-115,606
-47% -$20M
SNOW icon
36
Snowflake
SNOW
$115B
$20.2M 0.75%
+137,886
New +$23.4M
RCUS icon
37
Arcus Biosciences
RCUS
$3.64B
$20.1M 0.75%
2,560,904
+1,984,748
+344% +$23M
PVLA
38
Palvella Therapeutics
PVLA
$2.27B
$20M 0.74%
714,463
– –
DDOG icon
39
Datadog
DDOG
$84B
$18.2M 0.67%
183,231
+6,781
+4% +$856K
JNJ icon
40
Johnson & Johnson
JNJ
$625B
$18.1M 0.67%
109,386
-30,600
-22% -$4.79M
ABEO icon
41
Abeona Therapeutics
ABEO
$413M
$17.5M 0.65%
3,685,503
– –
ERAS icon
42
Erasca
ERAS
$6.39B
$16.9M 0.63%
12,315,004
– –
BIIB icon
43
Biogen
BIIB
$30.7B
$16.5M 0.61%
120,736
+5,300
+5% +$758K
CZR icon
44
Caesars Entertainment
CZR
$6.14B
$16.3M 0.61%
652,493
-119,919
-16% -$3.9M
AURA icon
45
Aura Biosciences
AURA
$826M
$16M 0.59%
+2,731,886
New +$20.7M
UNH icon
46
UnitedHealth
UNH
$370B
$15.7M 0.58%
29,900
-45,298
-60% -$23.2M
TTWO icon
47
Take-Two Interactive
TTWO
$46.1B
$15M 0.56%
+72,400
New +$14.5M
MRNA icon
48
Moderna
MRNA
$23.6B
$14.7M 0.54%
+517,163
New +$18.4M
FULC icon
49
Fulcrum Therapeutics
FULC
$297M
$14.6M 0.54%
5,067,394
+1,728,928
+52% +$6.35M
GS icon
50
Goldman Sachs
GS
$303B
$14M 0.52%
25,538
-48,660
-66% -$29.3M
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Suvretta Capital Management held 112 positions worth $2.69B, down 8.2% from $2.93B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Suvretta Capital Management's Q1 2025 filing shows 16 new, 29 increased, 14 reduced and 12 closed positions. Its largest new stake was Home Depot: 97,571 shares worth $35.8M. The largest sale was Intra-Cellular Therapies Inc., an estimated $92M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Suvretta Capital Management's largest Q1 2025 buy was Home Depot: 97,571 shares worth $35.8M.
  • Suvretta Capital Management added most to Ultragenyx Pharmaceutical in Q1 2025, an estimated $36.3M increase.
  • Suvretta Capital Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $92M.
  • Suvretta Capital Management fully exited Starbucks in Q1 2025, selling an estimated $47M.
  • Suvretta Capital Management's ten largest holdings make up 48% of its $2.69B portfolio in Q1 2025.
  • Suvretta Capital Management opened 16 new positions and closed 12 in Q1 2025.
  • Suvretta Capital Management's portfolio value fell 8.2% quarter-over-quarter to $2.69B.

Based on Suvretta Capital Management's 13F filing for Q1 2025, filed 15 May 2025.